生物谷
(920266)
| 流通市值：8.30亿 | | | 总市值：12.75亿 |
| 流通股本：8076.42万 | | | 总股本：1.24亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 304,011,258.04 | 207,571,938.26 | 92,118,348.63 | 516,232,107.07 |
| 营业收入 | 304,011,258.04 | 207,571,938.26 | 92,118,348.63 | 516,232,107.07 |
| 二、营业总成本 | 340,773,972.13 | 238,588,994.29 | 109,835,302.62 | 537,883,852.27 |
| 营业成本 | 122,693,097.38 | 87,077,703.61 | 44,564,931.5 | 139,940,745.88 |
| 税金及附加 | 6,039,296.88 | 4,127,337.88 | 1,678,595.71 | 10,106,151.48 |
| 销售费用 | 145,044,231.18 | 102,108,716.69 | 41,948,563.62 | 280,722,395.7 |
| 管理费用 | 57,297,613.01 | 37,771,928.29 | 18,220,315.97 | 93,412,243.69 |
| 研发费用 | 8,531,145.84 | 6,680,191.47 | 3,106,530.71 | 13,188,627.91 |
| 财务费用 | 1,168,587.84 | 823,116.35 | 316,365.11 | 513,687.61 |
| 其中:利息费用 | 1,641,776.96 | 1,195,505.82 | 541,774.36 | 2,726,573.61 |
| 其中:利息收入 | 488,646.7 | 383,518.89 | 233,517.96 | 2,233,095.29 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 677,990.39 | - | 837,201.82 |
| 加:投资收益 | 919,348.05 | 99,902.68 | 50,213.03 | 511,555.11 |
| 资产处置收益 | 886,020.43 | 739,105.08 | -2,093.73 | -2,238.68 |
| 资产减值损失(新) | 287,858.47 | 519,289.98 | -485,081.64 | -1,234,550 |
| 信用减值损失(新) | -2,424,215.71 | -1,303,511.28 | -368,158.34 | -61,301,650.4 |
| 其他收益 | 3,474,742.01 | 3,611,093.42 | 2,280,056.12 | 7,242,168.73 |
| 四、营业利润 | -33,618,960.84 | -26,673,185.76 | -16,242,018.55 | -75,599,258.62 |
| 加:营业外收入 | 335.44 | 274.06 | 274.05 | 196,730.58 |
| 减:营业外支出 | 293,236.16 | 292,782.89 | 50,183.75 | 2,037,173.01 |
| 五、利润总额 | -33,911,861.56 | -26,965,694.59 | -16,291,928.25 | -77,439,701.05 |
| 减:所得税费用 | 1,596,805.65 | 1,379,831.55 | 476,275.58 | -3,038,736.14 |
| 六、净利润 | -35,508,667.21 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -35,508,667.21 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -35,508,667.21 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 |
| 扣除非经常损益后的净利润 | -39,747,795.51 | -32,455,771.47 | -18,704,729.69 | -80,214,736.92 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.29 | -0.23 | -0.14 | -0.6 |
| (二)稀释每股收益 | -0.29 | -0.23 | - | -0.6 |
| 九、综合收益总额 | -35,508,667.21 | -28,345,526.14 | -16,768,203.83 | -74,400,964.91 |
| 归属于母公司股东的综合收益总额 | -35,508,667.21 | -28,345,526.14 | - | -74,400,964.91 |
| 公告日期 | 2025-10-29 | 2025-08-21 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 保留意见 |